Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Phytomedicine

• Publication date

  2014-09-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.phymed.2014.06.018PMID 25172795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.

  2013cited by this paper
• Acetylshikonin, a Novel AChE Inhibitor, Inhibits Apoptosis via Upregulation of Heme Oxygenase-1 Expression in SH-SY5Y Cells

  2013cited by this paper
• Identification of Anti-Malarial Compounds as Novel Antagonists to Chemokine Receptor CXCR4 in Pancreatic Cancer Cells

  2012cited by this paper
• Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation

  2012cited by this paper
• CXCR4/CXCL12 Participate in Extravasation of Metastasizing Breast Cancer Cells within the Liver in a Rat Model

  2012cited by this paper
• Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI

  2012cited by this paper
• CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy.

  2012cited by this paper
• Insights into the mechanism of enhanced mobilization of hematopoietic progenitor cells and release of CXCL12 by a combination of AMD3100 and aminoglycoside–polyarginine conjugates

  2011cited by this paper
• Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells.

  2011cited by this paper
• Acetyl‐11‐keto‐β‐boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression

  2011cited by this paper
• Chemokines and Cancer Progression: A Qualitative Review on the Role of Stromal Cell-derived Factor 1-alpha and CXCR4 in Endometrial Cancer

  2010cited by this paper
• CXCR4 and cancer

  2010cited by this paper
• Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists

  2010cited by this paper
• Silibinin--a promising new treatment for cancer.

  2010cited by this paper
• Targeting silibinin in the antiproliferative pathway

  2010cited by this paper
• Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells.

  2010cited by this paper
• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

  2009cited by this paper
• Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.

  2009cited by this paper
• Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells.

  2008cited by this paper
• Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro.

  2008cited by this paper
• Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells.

  2007cited by this paper
• Supplemental Data Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion

  2005cited by this paper
• Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.

  2004cited by this paper
• Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase‐plasminogen activator and matrix metalloproteinase‐2

  2004cited by this paper
• Regulation of CXCR4 expression in human T lymphocytes by calcium and calcineurin.

  2003cited by this paper
• T140 analogs as CXCR4 antagonists identified as anti‐metastatic agents in the treatment of breast cancer

  2003cited by this paper
• Phorbol Esters and SDF-1 Induce Rapid Endocytosis and Down Modulation of the Chemokine Receptor CXCR4

  1997cited by this paper
• Identification and Characterization of the CXCR4 Chemokine Receptor in Human T Cell Lines: Ligand Binding, Biological Activity, and HIV-1 Infectivity 1

  year unknowncited by this paper

• Basic mechanism of mobilizing cell movement during invasion of glioblastoma and target selection of targeted therapy.

  2025cites this paper
• The protection of bisphenol A-modulated miRNAs and targets by natural products.

  2025cites this paper
• C-X-C motif chemokine ligand 12—C-X-C chemokine receptor type 4 signaling axis in cancer and the development of chemotherapeutic molecules

  2024cites this paper
• Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification

  2024cites this paper
• Targeting chemokine-receptor mediated molecular signaling by ethnopharmacological approaches.

  2024cites this paper
• A novel method for exploration and prediction of the bioactive target of rice bran-derived peptide (KF-8) by integrating computational methods and experiments.

  2024cites this paper
• Proteomic Analysis of Staphylococcus aureus Treated with ShangKeHuangShui.

  2024cites this paper
• CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

  2023cites this paper
• Active constituents of herbal medicines for breast cancer: Current status

  2023cites this paper
• Shang-Ke-Huang-Shui and coptisine alleviate osteoarthritis in the knee of monosodium iodoacetate-induced rats through inhibiting CXCR4 signaling.

  2023cites this paper
• Role of Phytonutrients in Nutrigenetics and Nutrigenomics Perspective in Curing Breast Cancer

  2021cites this paper
• Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer

  2021cites this paper
• Silibinin Upregulates CXCR4 Expression in Cultured Bone Marrow Cells (BMCs) Especially in Pulmonary Arterial Hypertension Rat Model

  2020cites this paper
• -Role of natural compounds in preventing and treating breast cancer.

  2020cites this paper
• Transcriptome profiling reveals Silibinin dose-dependent response network in non-small lung cancer cells

  2020cites this paper
• Involvement of CXCR4 in Normal and Abnormal Development

  2019influential citation
• Chemokine Receptor Crystal Structures: What Can Be Learned from Them?

  2019cites this paper
• Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists.

  2019cites this paper
• Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia

  2019cites this paper
• Improvement of Cancer Therapy Using Phytochemicals

  2019cites this paper
• Overexpression of CXCR4 synergizes with LL-37 in the metastasis of breast cancer cells.

  2018cites this paper
• Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives

  2018cites this paper
• The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.

  2018cites this paper
• Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells.

  2018cites this paper
• Structural Analysis of Chemokine Receptor–Ligand Interactions

  2017cites this paper
• Herbalog: A tool for target-based identification of herbal drug efficacy through molecular docking.

  2016cites this paper
• The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines.

  2015cites this paper
• Tissue invasion and metastasis: Molecular, biological and clinical perspectives.

  2015cites this paper
• FORMULATION AND EVALUATION OF NANOSPONGE

  year unknowncites this paper